MedTrace Logo

Bioclinical Profile of Adenotonsillar Hypertrophy in the Pediatric Population

NCT03541434 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 134

Last updated 2019-04-16

No results posted yet for this study

Summary

Adenotonsillar hypertrophy is the principal cause of obstructive sleep apnea of childhood, yet little is known with regard to its pathophysiologic and molecular mechanisms. The present trial examines potential bioclinical markers of the disease.

Conditions

  • Enlargement of Tonsil or Adenoid

Interventions

DIAGNOSTIC_TEST

Complete Blood Count

White blood cell subgroups count

DIAGNOSTIC_TEST

Tympanometry

Conventional and multifrequency tympanometry, documenting middle ear admittance and absorbance

PROCEDURE

Tonsillectomy and/or adenoidectomy

Excision of palatine and/or pharyngeal tonsils.

Sponsors & Collaborators

  • University of Patras

    lead OTHER

Principal Investigators

  • Georgios T Stathopoulos · Associate Professor of Physiology

Eligibility

Min Age
1 Year
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2017-12-20
Completion
2018-06-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03541434 on ClinicalTrials.gov